Arrowhead appoints Patrick O'Brien as COO and General Counsel effective July 15, 2022

ARROWHEAD PHARMACEUTICALS, INC.

Patrick O'Brien (age 59) named Chief Operating Officer and General Counsel, effective July 15, 2022.
He retains roles as Chief Compliance Officer and Corporate Secretary.
O'Brien joined Arrowhead in December 2014 and previously served as General Counsel.
Over 25 years healthcare legal experience, including positions at Shire, Johnson & Johnson, and the FDA.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Patrick O'Brien

Chief Operating Officer and General Counsel

ARWR · ARROWHEAD PHARMACEUTICALS, INC.

Effective: 2022-07-15
Filed: July 20, 2022, 7:59 PM ET

Arrowhead Pharmaceuticals, Inc. (the “Company”) has appointed Patrick O’Brien, age 59, as Chief Operating Officer and General Counsel effective as of July 15, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Patrick O'Brien was appointed as Chief Operating Officer and General Counsel at ARROWHEAD PHARMACEUTICALS, INC..

Action: appointed
Role: Chief Operating Officer and General Counsel

Exact text from the filing

Arrowhead Pharmaceuticals, Inc. (the “Company”) has appointed Patrick O’Brien, age 59, as Chief Operating Officer and General Counsel effective as of July 15, 2022.

View on SEC.gov

ARROWHEAD PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001628280-22-019124

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.